Beneficial effects of adjuvant treatment using IFNγ for fungal infections in patients suffering from chronic granulomatous disease [17] HIV [23–25], leukemia [26, 27], and in organ transplant patients [28] were previously reported. This evidence concerns the gene IFNG and leukemia.